AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 45 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,051,000 | -39.3% | 1,945,975 | 0.0% | 0.00% | – |
| Q3 2016 | $1,732,000 | -7.4% | 1,945,975 | 0.0% | 0.00% | – |
| Q2 2016 | $1,870,000 | +4.5% | 1,945,975 | 0.0% | 0.00% | – |
| Q1 2016 | $1,790,000 | -27.0% | 1,945,975 | 0.0% | 0.00% | – |
| Q4 2015 | $2,452,000 | +4.1% | 1,945,975 | 0.0% | 0.00% | – |
| Q3 2015 | $2,355,000 | -40.4% | 1,945,975 | -14.3% | 0.00% | -100.0% |
| Q2 2015 | $3,951,000 | +20.5% | 2,270,793 | +0.4% | 0.00% | 0.0% |
| Q1 2015 | $3,279,000 | +75.0% | 2,261,434 | +1.4% | 0.00% | – |
| Q4 2014 | $1,874,000 | -24.3% | 2,229,873 | 0.0% | 0.00% | – |
| Q3 2014 | $2,475,000 | -37.5% | 2,229,873 | +3.0% | 0.00% | -100.0% |
| Q2 2014 | $3,962,000 | +5.4% | 2,165,142 | -13.9% | 0.00% | 0.0% |
| Q1 2014 | $3,760,000 | -45.1% | 2,514,764 | -32.8% | 0.00% | 0.0% |
| Q4 2013 | $6,848,000 | +56.0% | 3,741,996 | +75.6% | 0.00% | 0.0% |
| Q3 2013 | $4,389,000 | -13.9% | 2,130,749 | +4.5% | 0.00% | 0.0% |
| Q2 2013 | $5,099,000 | – | 2,039,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |